HAE251017C00070000 Option on Haemonetics

HAE Stock  USD 72.55  0.90  1.23%   
HAE251017C00070000 is a PUT option contract on Haemonetics' common stock with a strick price of 70.0 expiring on 2025-10-17. The contract was not traded in recent days and, as of today, has 89 days remaining before the expiration. The option is currently trading at a bid price of $5.0, and an ask price of $8.9. The implied volatility as of the 20th of July is 89.0.
When exercised, put options on Haemonetics produce a short position in Haemonetics Stock. Because of this protective nature, they are typically used either for hedging purposes or to capitalize on Haemonetics' downside price movement.

Rule 16 of 2025-10-17 Option Contract

The options market is anticipating that Haemonetics will have an average daily up or down price movement of about 0.0229% per day over the life of the option. With Haemonetics trading at USD 72.55, that is roughly USD 0.0166. If you think that the market is fully understating Haemonetics' daily price movement you should consider buying Haemonetics options at that current volatility level of 0.37%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

In The Money Call Option on Haemonetics

An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their Haemonetics positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on Haemonetics Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
Call Contract NameHAE251017C00070000
Expires On2025-10-17
Days Before Expriration89
Delta0.635991
Vega0.135283
Gamma0.02851
Theoretical Value6.95
Open Interest11
Strike Price70.0
Last Traded At7.0
Current Price Spread5.0 | 8.9
Rule 16 Daily Up or DownUSD 0.0166

Haemonetics short PUT Option Greeks

Haemonetics' Option Greeks for the contract ending on 2025-10-17 at a strike price of 70.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Haemonetics' option greeks, its implied volatility helps estimate the risk of Haemonetics stock implied by the prices of the options on Haemonetics' stock.
Delta0.635991
Gamma0.02851
Theta-0.032219
Vega0.135283
Rho0.096639

Haemonetics long PUT Option Payoff at expiration

Put options written on Haemonetics grant holders of the option the right to sell a specified amount of Haemonetics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Haemonetics Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Haemonetics is like buying insurance aginst Haemonetics' downside shift.
   Profit   
       Haemonetics Price At Expiration  

Haemonetics short PUT Option Payoff at expiration

By selling Haemonetics' put option, the investors signal their bearish sentiment. A short position in a put option written on Haemonetics will generally make money when the underlying price is above the strike price. Therefore Haemonetics' put payoff at expiration depends on where the Haemonetics Stock price is relative to the put option strike price. The breakeven price of 76.95 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Haemonetics' price. Finally, at the strike price of 70.0, the payoff chart is constant and positive.
   Profit   
       Haemonetics Price At Expiration  
View All Haemonetics Options

Haemonetics Available Call Options

Haemonetics' option chain is a display of a range of information that helps investors for ways to trade options on Haemonetics. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Haemonetics. It also shows strike prices and maturity days for a Haemonetics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
HAE251017C001350000135.00.0 - 2.152.15Out
Call
HAE251017C001300000130.00.0 - 2.152.15Out
Call
HAE251017C001250000125.00.0 - 2.152.15Out
Call
HAE251017C001200000120.00.0 - 2.152.15Out
Call
HAE251017C001150000115.00.0 - 2.152.15Out
Call
HAE251017C001100001110.00.0 - 1.81.8Out
Call
HAE251017C001050003105.00.0 - 2.22.2Out
Call
HAE251017C001000002100.00.0 - 2.32.3Out
Call
HAE251017C00095000395.00.0 - 2.42.4Out
Call
HAE251017C00090000090.00.0 - 2.652.65Out
Call
HAE251017C000850009385.00.0 - 3.22.27Out
Call
HAE251017C000800006980.00.85 - 4.43.3Out
Call
HAE251017C00075000575.02.15 - 6.35.6Out
Call
HAE251017C000700001170.05.0 - 8.97.0In
Call
HAE251017C000650001265.08.7 - 12.58.7In
Call
HAE251017C00060000160.012.8 - 16.612.8In
Call
HAE251017C00050000550.021.7 - 25.424.0In

Haemonetics Corporate Directors

Robert AbernathyIndependent DirectorProfile
Claire PomeroyIndependent DirectorProfile
Catherine BurzikIndependent DirectorProfile
Mark KrollIndependent DirectorProfile
When determining whether Haemonetics is a strong investment it is important to analyze Haemonetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Haemonetics' future performance. For an informed investment choice regarding Haemonetics Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haemonetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.946
Earnings Share
3.31
Revenue Per Share
27.038
Quarterly Revenue Growth
(0.04)
Return On Assets
0.0665
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.